The ATHENA Trial - Will It Change Treatment Of Atrial Fibrillation

Ole.Dyg Pedersen; Christian Torp-Pedersen

The ATHENA Trial - Will It Change Treatment Of Atrial Fibrillation

Ole.Dyg Pedersen, Christian Torp-Pedersen

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Udgivelsesdato: 2009

Original language	English
Journal	Healthcare Bulletin
Volume	1
Issue number	2
Publication status	Published - 2009

Cite this

@article{5406aae089a011df928f000ea68e967b,

title = "The ATHENA Trial - Will It Change Treatment Of Atrial Fibrillation",

abstract = "Udgivelsesdato: 2009",

author = "Ole.Dyg Pedersen and Christian Torp-Pedersen",

note = "Atrial fibrillation is the most common arrhythmia encountered in clinical practice. In the ATHENA trial (A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg bid for the Prevention...Author: Ole Dyg Pedersen, MD, DMSC, Christian Torp-Pedersen, MD, DMSC",

year = "2009",

language = "English",

volume = "1",

journal = "Healthcare Bulletin",

number = "2",

}

TY - JOUR

T1 - The ATHENA Trial - Will It Change Treatment Of Atrial Fibrillation

AU - Pedersen, Ole.Dyg

AU - Torp-Pedersen, Christian

N1 - Atrial fibrillation is the most common arrhythmia encountered in clinical practice. In the ATHENA trial (A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg bid for the Prevention...Author: Ole Dyg Pedersen, MD, DMSC, Christian Torp-Pedersen, MD, DMSC

PY - 2009

Y1 - 2009

N2 - Udgivelsesdato: 2009

AB - Udgivelsesdato: 2009

M3 - Journal article

VL - 1

JO - Healthcare Bulletin

JF - Healthcare Bulletin

IS - 2

ER -